Maravai LifeSciences Holdings shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint above estimates.

LABD

SBIO

<p>Maravai LifeSciences Holdings shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint above estimates.</p>

benzinga_article

SPDR S&P Health Equip

Direxion S&P Biotech Bear 3X

ALPS Medical Breakthrough

ReShape Lifesciences

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Maravai LifeSciences

iShares US Medical Devices

Invesco Nasdaq Biotechnology ETF

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

News